Genvion Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada (CAN)
- Operations here
- analysislabelmanufacturepackparticle size reductionrelabelrepack
- FDA identifiers
- FEI 3010164251 · DUNS 245221226
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-07-28
- NAIDrug Quality Assurance2016-06-17
Drugs this plant is listed as making
6 distinct drugs across 22 products name this site in their FDA label.
- efavirenz, emtricitabine and tenofovir disoproxil fumarateCipla USA Inc.
- Lanthanum CarbonateExelan Pharmaceuticals, Inc.
- lenalidomideExelan Pharmaceuticals Inc.
- NilotinibCipla USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.